The Future of CDMO Networks in Cell and Gene Therapy

This workshop will feature leading executives who will discuss a number of topics surrounding CDMO networks including bottlenecks in personnel capabilities and facilities along with preclinical pipeline driving capacity and workforce requirements. The session will also touch upon downstream requirements such as clinical sites capabilities, data systems, access and diversity, and regulatory bandwidth.


Chair:
Amritha Jaishankar, Ph.D., Executive Director, IQVIA Cell and Gene Therapy Translating Center


Speakers:
Eytan Abraham, Ph.D., Vice President, Business Head of Cell, Gene and Nucleic Acids Franchises, Resilience
Abla Creasey, Ph.D., Vice President, Therapeutics Development, California Institute for Regenerative Medicine (CIRM)
Haro Hartounian, Ph.D., President and CEO, BioCentriq
Alan Moore, Chief Strategy Officer, Center for Breakthrough Medicines
Nicholas Ostrout, Ph.D., Senior Advisor, Cell and Gene Therapy Corporate Strategy, Charles River Laboratories